The number of pharmaceutical suppliers and retailers accused of inflating prices by the Trade Competition & Consumer Protection Authority (TCCPA) has now reached 19, with 11 importers added to the list along with the previously charged eight wholesalers.
The Authority’s case processor filed a charge on the 11 importers on December 26, 2017, accusing them of increasing prices of imported medicines and medical equipment by three percent to 100pc since October 11, 2017.
Their charges were filed in two separate cases, alleging all of them of price inflation and accusing only five of them of abusing of their market dominance.
In the second file, the Authority claims that Beker General Business Plc, Dat International Trading, Pharma Berber Plc, Amba Pharmaceuticals Plc and Karoga Pharmaceuticals Plc abused the customers after agreeing to inflate the price.
Along with the five companies Kefiyalew Gari, Droga Pharma Plc, Mefana Import & Export Plc, Shitama International Trading Plc, Hamernola Pharmaceutical Plc and Afri-med General Importer, are accused of fixing the market price with a simultaneous price increase.
The plaintiff seeks a penalty of 10pc of the annual turnover of all companies and additional 10pc fine for the five companies in the second file.